Medical Advisor Spotlight: Anatoly Dritschilo, MD is RetinalGeniX’s Senior Advisor of Pharmaco-Genetics, leveraging his expertise and over 40 years of experience to further our mission. He serves as a Senior Consultant to assist with our Pharmaco-Genetic anti-VEGF study and the suitability of ocular injection therapy to patients prior to its use. In addition, he oversees our Anti-VEGF study for the benefit of patients worldwide. His full bio can be found here: https://bit.ly/4ieTMYR #RetinalGenix #MedicalAdvisor #AdvisoryBoard #RetinalImaging
RetinalGeniX Technologies, Inc.
医疗设备制造业
Apollo Beach，Florida 39 位关注者
Innovating early detection & treatment of ocular & systemic diseases with hi-res. retinal imaging and pharmacogenetics.
关于我们
RetinalGenix Technologies is transforming the future of healthcare by providing advanced solutions for the early detection and treatment of both ocular and systemic diseases. We know that the eyes are the gateway to the body, revealing vital early signs of diseases like Alzheimer's, cardiovascular issues, and diabetes—often before they manifest elsewhere. Our groundbreaking high-resolution retinal imaging, combined with our proprietary DNA/RNA GPS? pharmacogenetic mapping technology, allows us to detect these conditions earlier, providing doctors with real-time data that leads to faster, more accurate diagnosis and more personalized treatments. Imagine a world where sight-threatening conditions and systemic diseases can be identified before symptoms even begin. With RetinalGeniX, that future is now. Our innovative technologies enable 24/7 remote monitoring, giving healthcare providers the tools they need to assess patient health from anywhere, anytime. This means less reliance on costly, invasive procedures like MRIs or PET scans—cutting both patient time and healthcare costs. We don’t stop there. Our platform goes beyond detection. We integrate this cutting-edge retinal data with pharmacogenetic testing to validate new therapeutic approaches, guiding the development of novel drugs and treatments. This holistic approach positions RetinalGeniX at the forefront of medical innovation, providing unparalleled value to physicians, payors, and patients alike. Join us on our mission to prevent blindness, treat systemic diseases early, and improve the quality of life for millions.
- 网站
-
https://retinalgenix.com
RetinalGeniX Technologies, Inc.的外部链接
- 所属行业
- 医疗设备制造业
- 规模
- 11-50 人
- 总部
- Apollo Beach，Florida
- 类型
- 上市公司
- 创立
- 2002
- 领域
- Ophthalmic Research、Retinal Imaging、Medical Diagnostics、Ocular Disease Management、Genetic Testing、Pharmacogenetics、Telemedicine、Digital Health Solutions、Artificial Intelligence in Healthcare、Biotechnology、Neurodegenerative Disease Detection、Medical Device Development、Remote Patient Monitoring、High-Resolution Imaging、Precision Medicine、Precision Medicine和Systemic Disease Management
地点
-
主要
获取路线
409 Apollo Beach Blvd
6
US，Florida，Apollo Beach，33572
RetinalGeniX Technologies, Inc.员工
-
Lisa Davis
Marketing Consultant
-
Dessy Boneva, MD, FACS
Trauma Surgeon, University of South Florida
-
Jerry Katzman M.D.
Visionary Medical Entrepreneur | CEO @ RetinalGeniX Technologies | Pioneer in AI & Retinal Imaging | Precision Medicine Advocate | Genetic Biomarker…
-
Stephen Tannenbaum
Commercial Real Estate Lending @ SRT and SUNS || Advisor | Board Member
动态
-
Our high-resolution retina mass screening device integrates advanced optical systems and sophisticated software algorithms to deliver sharp, high-resolution images, revealing intricate details of the retina that are crucial for early diagnosis of conditions like macular degeneration, diabetic retinopathy, and glaucoma. The device also detects initial physiological changes that could indicate possible future systemic disease including neurodegenerative, cardiovascular, vascular, metabolic, and diabetic conditions. Learn more: https://bit.ly/3EAUUah #RetinalImaging #OpticalSolutions #Retina #EyeHealth #AMD #Glaucoma #EyeDisease #OcularDiseases #SystemicDiseases #Imaging
-
-
Next week, RetinalGeniX will be participating at the 37th Annual Roth Conference in Dana Point, CA, March 16-18, 2025. CEO Jerry Katzman M.D., will be in attendance during the conference and will be available for 1-on-1 meetings on March 17-18. Interested investors should contact their ROTH representative or submit a registration request at https://lnkd.in/gifDJ92N ROTH Capital Partners
-
-
RetinalGeniX Technologies (Symbol: RTGN) to Participate at the 37th Annual Roth Conference on March 16th to the 18th. The company will highlight its proprietary high-resolution, real-time retinal and ocular imaging and monitoring RetinalCam?, which is currently imaging patients and is in the prototype stage. CEO Jerry Katzman M.D., will be in attendance during the conference and will be available for 1-on-1 meetings on March 17th and 18th. Read the press release here: https://lnkd.in/gpf9wZtU ROTH Capital Partners
-
-
RetinalGeniX’s high-resolution retinal mass screening device represents a groundbreaking leap in ocular health technology, meticulously engineered to enhance early detection and management of retinal disorders. Designed with precision, it offers unparalleled clarity and depth in retinal imaging, enabling healthcare professionals to conduct comprehensive screenings with ease and efficiency. Learn more about the screening device: https://bit.ly/4gKzl4R #RetinalGenix #RetinalImaging #EyeCare #SystemicDiseases #OcularDisease #EyeHealth #Healthcare
-
-
RetinalGeniX Technologies starts imaging patients with prototype high-resolution retinal imaging device. The device uses both near-infrared and green modes and is designed to enable secure, real-time remote monitoring around the clock, from virtually any location. Read more Retinal Physician: https://bit.ly/3EOntl0 #RetinalImaging #MedTech #EyeHealth #Ophthalmology #MedicalDevice #Heatlhcare
-
RetinalGeniX Technologies begins testing remote ocular monitoring system. The high-resolution #retinalimaging device and remote monitoring system now uses both near infrared and green modes. Dive into the article via Ophthalmology Times: https://bit.ly/41A89RZ #RetinalImaging #OpticalSolutions #Retina #EyeHealth #AMD #Glaucoma #EyeDisease #OcularDiseases #SystemicDiseases #Imaging #MedTech
-
CEO Spotlight: Meet Jerry Katzman M.D., RetinalGeniX’s Chairman, President and CEO. With a rich career marked by entrepreneurship, medical science, and innovation, Dr. Katzman is a recognized leader in the fields of biotechnology, biopharma, and healthcare financial sectors. Dr. Katzman’s full bio can be found here: https://bit.ly/43ggs6K #RetinalGenix #RetinalImaging #EyeCare #SystemicDiseases #OcularDisease #EyeHealth #FutureofEyeCare #Biotech #Biopharma #Healthcare
-
-
RetinalGeniX Develops Remote Imaging Device. RetinalGeniX successfully started imaging patients with its first prototype of its high-resolution retinal imaging device and monitoring system using both near-infrared and green modes. The imaging system is designed to allow routine screenings to be conducted by general practitioners, optometric technicians and clinics. Read more Retinal Physician: https://bit.ly/3EOntl0 #RetinalImaging #MedTech #EyeHealth #Ophthamology #MedicalDevice #Heatlhcare
-
Stay ahead! Sign up to get updates, information and news about RetinalGeniX. Subscribe at the bottom of the page: https://bit.ly/3EAUUah #RetinalGenix #RetinalImaging #EyeCare #SystemicDiseases #OcularDisease #EyeHealth
-